Biomedical Research Centre, Institute of Nutrition and Food Technology "José Mataix Verdú", Department of Physiology, Faculty of Pharmacy, University of Granada, Avda. Del Conocimiento S/n, 18100, Armilla, Granada, Spain; College of Food Science and Technology, Northwest University, Xi'an, 710069, China.
Biomedical Research Centre, Institute of Nutrition and Food Technology "José Mataix Verdú", Department of Physiology, Faculty of Pharmacy, University of Granada, Avda. Del Conocimiento S/n, 18100, Armilla, Granada, Spain; Sport and Health Research Centre. University of Granada, C/. Menéndez Pelayo 32, 18016, Armilla, Granada, Spain.
Environ Res. 2020 Dec;191:110053. doi: 10.1016/j.envres.2020.110053. Epub 2020 Aug 22.
The repositioning of therapeutic agents already approved by the regulatory agencies for the use of drugs is very interesting due to the immediacy of their use; similarly, the possibility of using molecules derived from foods, whether nutrients or not, is of great importance, also because of their immediate therapeutic applicability. Candidates for these natural therapies against COVID-19 should show certain effects, such as restoring mitochondrial function and cellular redox balance. This would allow reducing the susceptibility of risk groups and the cascade of events after SARS-CoV-2 infection, responsible for the clinical picture, triggered by the imbalance towards oxidation, inflammation, and cytokine storm. Possible strategies to follow through the use of substances of food origin would include: a) the promotion of mitophagy to remove dysfunctional mitochondria originating from free radicals, proton imbalance and virus evasion of the immune system; b) the administration of transition metals whose redox activity would lead to their own oxidation and the consequent generation of a reduced environment, which would normalize the oxidative state and the intracellular pH; c) the administration of molecules with demonstrated antioxidant capacity; d) the administration of compounds with anti-inflammatory and vasodilatory activity; e) the administration of immunomodulatory compounds.
由于这些药物可以立即使用,因此重新定位已经获得监管机构批准的治疗药物非常有趣;同样,使用源自食物的分子(无论是否为营养物质)的可能性也非常重要,这同样也是因为其具有直接的治疗适用性。针对 COVID-19 的这些天然疗法的候选药物应该具有某些作用,例如恢复线粒体功能和细胞氧化还原平衡。这将有助于降低风险人群的易感性,以及减少由 SARS-CoV-2 感染引发的级联事件,这些事件由氧化、炎症和细胞因子风暴失衡引起的临床症状所触发。通过使用源自食物的物质的可能的治疗策略包括:a)促进线粒体自噬以去除源自自由基、质子失衡和病毒逃避免疫系统的功能失调的线粒体;b)给予具有氧化还原活性的过渡金属,这将导致其自身氧化并产生还原环境,从而使氧化状态和细胞内 pH 值正常化;c)给予具有已证明抗氧化能力的分子;d)给予具有抗炎和血管舒张活性的化合物;e)给予具有免疫调节作用的化合物。